SCNI Latest Press Releases

-- October 20, 2026 --

Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing PRNewswire 8:50 AM

-- October 16, 2026 --

Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement PRNewswire 8:01 AM

-- October 14, 2026 --

Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement PRNewswire 8:00 AM

-- October 13, 2026 --

Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement PRNewswire 7:01 AM

-- September 21, 2026 --

Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement PRNewswire 7:00 AM

-- September 8, 2026 --

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business PRNewswire 9:19 AM

-- August 24, 2026 --

Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum PRNewswire 7:01 AM

-- August 10, 2026 --

Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration PRNewswire 6:35 AM

-- June 10, 2026 --

Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives PRNewswire 7:55 AM

Market Data Delayed 15 Minutes